Hong Kong Stock Market Movements | Hansoh Pharmaceutical (03692.HK) rose nearly 3% in the afternoon after receiving the clinical trial approval notice for HS-10582 issued by the NMPA.

Zhiyun Finance APP learned that Hansoh Pharmaceutical (03692.HK) rose nearly 3% in the afternoon. As of the time of publication, it was up 2.27%, priced at HKD 32.4, with a trading volume of HKD 136 million.